Another drug has been approved by the FDA in May 2013. Xofigo (radium -233 dichloride). This drug is to be used for prostrate cancer survivors who are now in an unfortunate castration resistant stage. Xofigo is approved for treating cancer that had spread to the bones but not yet to any organ in the body.
Xofigo is marketed by Bayer Pharmaceuticals.
Read Xofigo here :
http://www.cancer.org/cancer/news/news/fda-approves-xofigo-for-advanced-prostate-cancer
Take care
Allen
No comments:
Post a Comment